DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ryan AM, Sokolowski SA, Ng CK et al.
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®).
Toxicol Pathol 2014;
42: 1069-1081
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.